SYNTHETIC LONG PEPTIDES (SLP) FOR THERAPEUTIC VACCINATION AGAINST HEPATITIS B VIRUS INFECTION

The present invention relates to the fields of medicine and immunology. In particular, it relates to novel peptides that may be used in the treatment and/or prevention of a Hepatitis B viral infection and/or an Hepatitis B related disease or condition. La présente invention concerne les domaines de...

Full description

Saved in:
Bibliographic Details
Main Authors KREBBER, WILHELMUS JOHANNES THEODORUS ALEXANDER, MELIEF, CORNELIS JOSEPH MARIA, KESSLER, JOHAN HERMAN, KWAPPENBERG, KITTY MICHELLE CORINNE
Format Patent
LanguageEnglish
French
Published 10.12.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the fields of medicine and immunology. In particular, it relates to novel peptides that may be used in the treatment and/or prevention of a Hepatitis B viral infection and/or an Hepatitis B related disease or condition. La présente invention concerne les domaines de la médecine et de l'immunologie. En particulier, l'invention concerne de nouveaux peptides qui peuvent être utilisés dans le traitement et/ou la prévention d'une infection par le virus de l'hépatite B et/ou d'une maladie ou affection liée à l'hépatite B.
Bibliography:Application Number: CA20152950863